关于：正常骨髓中表达白血病相关免疫表型的原始粒细胞。 - Suppr

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

作者信息

Hanekamp Diana, Bachas Costa, van de Loosdrecht Arjan, Ossenkoppele Gert, Cloos Jacqueline

机构信息

Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.

出版信息

Pathology. 2020 Feb;52(2):289-291. doi: 10.1016/j.pathol.2019.09.021. Epub 2019 Dec 26.

DOI:10.1016/j.pathol.2019.09.021

PMID:31883670

Abstract

摘要

相似文献

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

Pathology. 2020 Feb;52(2):289-291. doi: 10.1016/j.pathol.2019.09.021. Epub 2019 Dec 26.

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes: author reply.

Pathology. 2020 Feb;52(2):291. doi: 10.1016/j.pathol.2019.11.005. Epub 2020 Jan 9.

Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

Pathology. 2019 Aug;51(5):502-506. doi: 10.1016/j.pathol.2019.03.010. Epub 2019 Jun 29.

Partial maturation of leukemic myeloblasts following plasma transfusions.

Am J Med Sci. 1947 Feb;213(2):170-5.

[OXIDASE-NEGATIVE MYELOBLASTS IN NORMAL BONE MARROW].

Nihon Ketsueki Gakkai Zasshi. 1963 Feb;26:122-4.

Flow cytometric immunophenotyping of leukemia cells in clotted blood and bone marrow.

J Immunol Methods. 1991 Mar 21;137(2):193-7. doi: 10.1016/0022-1759(91)90024-a.

[ON OXIDASE-NEGATIVE MYELOBLASTS IN LEUKEMIA WITH SPECIAL REFERENCE TO THEIR ELECTRON MICROSCOPE PICTURE].

Nihon Ketsueki Gakkai Zasshi. 1963 Feb;26:139-42.

[Trial of statistical interpretation of the maturation and division of erythroblasts and myeloblasts; its formulation in the system of logarithms to the base 2].

Rev Hematol. 1956 Jan-Mar;11(1):8-16.

[Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation].

Korean J Lab Med. 2007 Dec;27(6):406-13. doi: 10.3343/kjlm.2007.27.6.406.

[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].

Folia Med Cracov. 2001;42(3):5-80.

引用本文的文献

False-Positive and False-Negative MRD Results in Children with Acute Lymphoblastic Leukemia: Navigating Between Scylla and Charybdis (Brief Review and Clinical Experience).

Children (Basel). 2025 Jun 30;12(7):860. doi: 10.3390/children12070860.

Acute Myeloid Leukemia-Use of Measurable Residual Disease to Improve Outcomes.

Adv Exp Med Biol. 2025;1475:129-148. doi: 10.1007/978-3-031-84988-6_7.

Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models.

Commun Med (Lond). 2024 Dec 19;4(1):271. doi: 10.1038/s43856-024-00700-x.

Detection methods and prognosis implications of measurable residual disease in acute myeloid leukemia.

Ann Hematol. 2024 Dec;103(12):4869-4881. doi: 10.1007/s00277-024-06008-z. Epub 2024 Sep 16.

Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.

Int J Mol Sci. 2024 Feb 10;25(4):2150. doi: 10.3390/ijms25042150.

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML.

Hemasphere. 2023 Nov 21;7(12):e981. doi: 10.1097/HS9.0000000000000981. eCollection 2023 Dec.

Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial.

Haematologica. 2022 Dec 1;107(12):2823-2833. doi: 10.3324/haematol.2021.279777.

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.

Hemasphere. 2021 Dec 22;6(1):e676. doi: 10.1097/HS9.0000000000000676. eCollection 2022 Jan.

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.

Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626.

AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML.

Cancers (Basel). 2021 May 26;13(11):2597. doi: 10.3390/cancers13112597.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

作者信息

Hanekamp Diana, Bachas Costa, van de Loosdrecht Arjan, Ossenkoppele Gert, Cloos Jacqueline

机构信息

Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.

出版信息

Pathology. 2020 Feb;52(2):289-291. doi: 10.1016/j.pathol.2019.09.021. Epub 2019 Dec 26.

DOI:10.1016/j.pathol.2019.09.021

PMID:31883670

Abstract

摘要

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

作者信息

机构信息

出版信息

相似文献

引用本文的文献